Pre-clinical (normoalbuminuria) - 修訂歷史

Guhjy在2018年3月27日 (二) 09:09

Guhjy — Tue, 27 Mar 2018 09:09:50 GMT

←上一修訂		在2018年3月27日 (二) 09:09所做的修訂版本
第3行：		第3行：
	*Mesangial expansion/sclerosis (PAS+)		*Mesangial expansion/sclerosis (PAS+)
	*Pathogenesis		*Pathogenesis
-	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor- &beta, hyperlipidemia	+	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-β, hyperlipidemia

Guhjy在2018年3月27日 (二) 04:59

Guhjy — Tue, 27 Mar 2018 04:59:34 GMT

←上一修訂		在2018年3月27日 (二) 04:59所做的修訂版本
第3行：		第3行：
	*Mesangial expansion/sclerosis (PAS+)		*Mesangial expansion/sclerosis (PAS+)
	*Pathogenesis		*Pathogenesis
-	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&beta, hyperlipidemia	+	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor- &beta, hyperlipidemia

Guhjy在2018年3月27日 (二) 04:59

Guhjy — Tue, 27 Mar 2018 04:59:21 GMT

←上一修訂		在2018年3月27日 (二) 04:59所做的修訂版本
第3行：		第3行：
	*Mesangial expansion/sclerosis (PAS+)		*Mesangial expansion/sclerosis (PAS+)
	*Pathogenesis		*Pathogenesis
-	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-/beta, hyperlipidemia	+	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&beta, hyperlipidemia

Guhjy在2018年3月27日 (二) 04:55

Guhjy — Tue, 27 Mar 2018 04:55:53 GMT

←上一修訂		在2018年3月27日 (二) 04:55所做的修訂版本
第3行：		第3行：
	*Mesangial expansion/sclerosis (PAS+)		*Mesangial expansion/sclerosis (PAS+)
	*Pathogenesis		*Pathogenesis
-	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&beta, hyperlipidemia	+	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-/beta, hyperlipidemia

Guhjy在2018年3月27日 (二) 04:51

Guhjy — Tue, 27 Mar 2018 04:51:18 GMT

←上一修訂		在2018年3月27日 (二) 04:51所做的修訂版本
第3行：		第3行：
	*Mesangial expansion/sclerosis (PAS+)		*Mesangial expansion/sclerosis (PAS+)
	*Pathogenesis		*Pathogenesis
-	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&b, hyperlipidemia	+	**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&beta, hyperlipidemia

Guhjy: 新頁面: Urinary albumin excretion< 30 mg/g creatinine < 5 year, renal hypertrophy, hyperfiltration, intrarenal hypertension, thick GBM (cannot predict progression), loss of heparan sulfate (neg...

Guhjy — Tue, 27 Mar 2018 04:48:14 GMT

新頁面: *Urinary albumin excretion< 30 mg/g creatinine *< 5 year, renal hypertrophy, hyperfiltration, intrarenal hypertension, thick GBM (cannot predict progression), loss of heparan sulfate (neg...

新頁面

*Urinary albumin excretion< 30 mg/g creatinine
*< 5 year, renal hypertrophy, hyperfiltration, intrarenal hypertension, thick GBM (cannot predict progression), loss of heparan sulfate (negative charge)-->albuminuria
*Mesangial expansion/sclerosis (PAS+)
*Pathogenesis
**Glomerular hypertension, hyperfiltration, proteinuria, hyperglycemia, advanced glycosylation end products, growth hormone, atrial natriuretic peptide, insulin-like growth factor I, angiotensin II (efferent arteriole constriction), connective tissues growth factor, transforming growth factor-&b, hyperlipidemia

Pre-clinical (normoalbuminuria) - 修訂歷史

Guhjy在2018年3月27日 (二) 09:09

Guhjy在2018年3月27日 (二) 04:59

Guhjy在2018年3月27日 (二) 04:59

Guhjy在2018年3月27日 (二) 04:55

Guhjy在2018年3月27日 (二) 04:51

Guhjy: 新頁面: *Urinary albumin excretion< 30 mg/g creatinine *< 5 year, renal hypertrophy, hyperfiltration, intrarenal hypertension, thick GBM (cannot predict progression), loss of heparan sulfate (neg...

Guhjy: 新頁面: Urinary albumin excretion< 30 mg/g creatinine < 5 year, renal hypertrophy, hyperfiltration, intrarenal hypertension, thick GBM (cannot predict progression), loss of heparan sulfate (neg...